Featured Articles
-
5 Key Considerations For Companies Outsourcing Process Development
6/9/2025
Venture capital in biotech remains strong post-pandemic, especially in cell and gene therapies. Discover five key factors to help companies choose between in-house and outsourced process development strategies.
-
Face The Unknown: Key Bispecific Antibody Discoveries
5/16/2025
Bispecific antibodies (BsAbs) are revolutionizing biopharmaceuticals with enhanced therapeutic potential. Learn how advanced design tools and expert support streamline BsAb development from concept to clinic.
-
21st Century Manufacturing Of Injectable Pharmaceuticals
5/12/2025
Discover how rising competition, niche patient populations, and evolving therapies are reshaping sterile injectable drug development with cutting-edge technologies.
-
A Shift Towards Biofluorescent Particle Counters In Manufacturing
5/12/2025
Sterility in injectable drug manufacturing is vital for patient safety and efficiency. Discover how biofluorescent particle counters revolutionize contamination control, regulatory compliance, and operational excellence in modern pharma.
-
What Is The Position Of Regulatory Authorities On PUPSIT?
5/2/2025
PUPSIT and other integrity testing methods are crucial for manufacturers to reduce contamination risks and ensure drug product safety. Learn how your company can adhere to updated regulatory guidelines.
-
Five Considerations For PUPSIT Implementation
5/2/2025
Pre-use, post-sterilization integrity testing (PUPSIT) is vital for contamination control to ensure the integrity of sterilized equipment before use. Learn how PUPSIT can enhance safety and quality in your protocols.
-
How Robotic Isolator Technology Aligns To Annex 1 Principles
4/28/2025
Robotic gloveless isolators provide exceptional automation to eliminate human intervention and reduce contamination risk. Discover how they ensure compliance with the EU Annex 1 guideline to enhance sterility, precision, and monitoring.
-
Economic Advantage Of Robotic Gloveless Pharmaceutical Isolators
4/28/2025
Are robotic gloveless isolators the key to smarter, safer, scalable solutions? Discover how they can revolutionize aseptic filling by reducing contamination, minimizing waste, and enhancing manufacturing flexibility.
-
Biofluorescent Particle Counters Are Gaining Momentum
4/28/2025
The 2025 BioPhorum report highlights challenges and trends in drug filling operations and how they are advancing towards biofluorescent particle counters. Discover an approach that aligns with industry needs.
-
CDMO Uses Robotic Gloveless Isolator For Advanced Therapeutics
4/28/2025
CDMOs must innovate production architectures to meet the demands of advanced therapeutics to ensure a reliable supply and compliance. Discover how these approaches advance modern medicine and improve patient outcomes.